Get started
Author

Myriam De la Cruz Puebla

Observed names: M. De la Cruz-Puebla, Myriam De La Cruz Puebla, Myriam De la Cruz, Myriam De la Cruz-Puebla, Myriam De la Cruz‐Puebla, Myriam Dela Cruz-Puebla, Myriam de la Cruz
Observed institutions: Universitat Autònoma de Barcelona, University of California, San Francisco, Trinity College Dublin, Institut d'Investigació Biomédica de Bellvitge, Vall d'Hebron Institut de Recerca, Hospital Clínic de Barcelona, Universidad Técnica de Ambato, Global Brain Health Institute, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona
ORCID: 0000-0002-8878-0974
Observed ORCID: 0000-0002-8878-0974
OpenAlex ID: A5028046017
Dementia in Latin America: Paving the way toward a regional action plan
2020 · Mario Alfredo Parra, Sandra Baez, et al. · Alzheimer s & Dementia · 148
PDF
Facilitators and Barriers to Dementia Assessment and Diagnosis: Perspectives From Dementia Experts Within a Global Health Context
2022 · Alissa Bernstein Sideman, Tala Al-Rousan, et al. · Frontiers in Neurology · 99
Biomarkers for dementia in Latin American countries: Gaps and opportunities
2022 · Mario A. Parra, Paulina Orellana, et al. · Alzheimer s & Dementia · 54
PDF
The impact of SARS‐CoV‐2 in dementia across Latin America: A call for an urgent regional plan and coordinated response
2020 · Agustin Ibanez, Hernando Santamaria‐Garcia, et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 28
PDF
Designing an app for home-based enriched Music-supported Therapy in the rehabilitation of patients with chronic stroke: a pilot feasibility study
2021 · Emma Segura, Jennifer Grau-Sánchez, et al. · Brain Injury · 19
PDF
Enriched music-supported therapy for individuals with chronic stroke: a randomized controlled trial
2024 · Emma Segura, Jennifer Grau-Sánchez, et al. · Journal of Neurology · 16
Global Perspectives on Brief Cognitive Assessments for Dementia Diagnosis1
2021 · Elena Tsoy, Alissa Bernstein Sideman, et al. · Journal of Alzheimer s Disease · 16
Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas
2019 · Daniel Pilco-Janeta, Myriam De la Cruz Puebla, et al. · BMC Cancer · 10
PDF
Reward-based decision-making in mesial temporal lobe epilepsy patients with unilateral hippocampal sclerosis pre- and post-surgery
2022 · Adrià Vilà-Balló, Myriam De la Cruz-Puebla, et al. · NeuroImage Clinical · 4
PDF
Gastric Cancer Mortality-to-Incidence Ratios in Latin America and the Caribbean: A Machine Learning Analysis of Socioeconomic and Clinical Research Predictors
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al. · JCO Global Oncology · 2
PDF
The evolving landscape of KRAS-targeted therapy: mechanisms of resistance and emerging strategies
2025 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla · Anti-Cancer Drugs · 2
Long-term response to aminopyridines in a cohort of patients with ataxia associated with downbeat nystagmus due to the FGF14 GAA expansion
2025 · E. Muñoz, M. De la Cruz-Puebla, et al. · Neurología · 1
De novo depression following temporal lobe epilepsy surgery
2024 · Jacint Sala-Padro, Myriam De la Cruz-Puebla, et al. · Seizure · 1
PDF
Supplementary Table S9 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Figure 1 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary FIgure S2 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Figure 3 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S10 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S2 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Data from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Figure 4 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S12 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S7 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S4 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S11 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Works count: 37
Citation count: 398
H-index: 8
I10-index: 8
Year
Topic
Type